OBJECTIVE The aim of this study was to explore Jordanian patients' perceptions toward generic medicines and to evaluate their opinions regarding generic substitution. METHOD A cross-sectional descriptive study involving Jordanian patients was undertaken, using a self-administrated anonymous questionnaire. The response rate was 80% (n=400/500). RESULTS The study showed that cost of medicines...

The impact of a reform that increased consumer information on brand name and generic pharmaceutical prices is analyzed both theoretically and empirically. The theoretical results show that an increase in information likely reduces the price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper, the introduction of the substitution...

Generics are statements that are not explicitly quantified and that express generalizations, such as ‘ducks lay eggs’. Intuitively, the generic (non-quantified) form of such statements seems to be true. Furthermore, people seem to be prone to an interesting error: treating the universal form of characteristic generic assertions (e.g., ‘all ducks lay eggs’) as true, even though they are, upon a ...

The development of complex software requires the implementation of functions over a variety of recursively defined data structures. Much of the corresponding code is not necessarily difficult, but more tedious and/or repetitive and sometimes easy to get wrong. Data structure traversals fall into this category, particularly in object-oriented languages where traversal code is spread throughout m...

As a result of the regulatory focus on using a Quality by Design (QbD) approach for ANDAs, generics manufacturers are placing increasing emphasis on the analytical tools that support its application. Most especially, there is a requirement for analytical technologies that help to scope the product design space efficiently. This is the multiparametric space in which the properties that define cl...

What?s in a name? A brand-name drug and its generic counterpart are chemically the same. They may have different names, colors, and shapes, but the United States Food and Drug Administration (FDA) requires generic drugs to share several similarities as the brand-name counterparts (more on this later). And, while there are some differences, generics don?t really change the effectiveness of the d...

A Dagstuhl Seminar on the topic of Generic Programming was held April 27{ May 1, 1998, with forty seven participants from ten countries. During the meeting there were thirty seven lectures, a panel session, and several problem sessions. The outcomes of the meeting include A collection of abstracts of the lectures, made publicly available via this booklet and a web site at Plans for a proceeding...

The generic drug and branded drug is a confusing concept, and is a matter of serious concern for the pharmaceutical sector after the imposition of the rule that every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs. The generic drug should be bioequivalent before they can...

What?s in a name? A brand-name drug and its generic counterpart are chemically the same. They may have different names, colors, and shapes, but the United States Food and Drug Administration (FDA) requires generic drugs to share several similarities as the brand-name counterparts (more on this later). And, while there are some differences, generics don?t really change the effectiveness of the d...

While using the brand names seems like a trivial issue at the outset, using these names is inherently problematic. Cardiovascular drugs remain the most commonly prescribed drugs by the physicians. The junior doctors are likely to introject practices of their seniors and consequently to reciprocate from the experiences learnt from their preceptors. Using the generic names may be one way to facil...